BlueWillow Biologics

Recent Finacing

Series A

Recent Raise

$10M

BlueWillow Biologics develops and commercializes intranasal and intramuscular nanoemulsion-adjuvanted vaccines and topical anti-infective dermatology products targeting respiratory, sexually transmitted, and other infectious diseases.

Founded 2000

Michigan, United States

11-50

Private

bluewillow.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Nanotechnology

Recent Investors

L

Financials

$21M

Total Raised

2

Funding rounds

3

Investors

Team

Upgrade to view the team

See the team members at BlueWillow Biologics.